The Rhinitis drugs in development market research report provides comprehensive information on the therapeutics under development for Rhinitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Rhinitis. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Rhinitis and features dormant and discontinued products.
GlobalData tracks nine drugs in development for Rhinitis by six companies/universities/institutes. The top development phase for Rhinitis is phase i with four drugs in that stage. The Rhinitis pipeline has nine drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Rhinitis pipeline products market are: Korea United Pharm, Cellix Bio and ARS Pharmaceuticals.
The key targets in the Rhinitis pipeline products market include Histamine H1 Receptor (HRH1), Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 or NR3C1), and 5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR).
The key mechanisms of action in the Rhinitis pipeline product include Histamine H1 Receptor (HRH1) Antagonist with two drugs in Discovery. The Rhinitis pipeline products include three routes of administration with the top ROA being Nasal and two key molecule types in the Rhinitis pipeline products market including Small Molecule, and Synthetic Peptide.
Rhinitis overview
Rhinitis is inflammation and swelling of the mucous membrane of the nose, characterized by a runny nose and stuffiness and usually caused by the common cold or a seasonal allergy. Rhinitis is classified as allergic or nonallergic. The cause of nonallergic rhinitis is usually a viral infection, although irritants can cause it. The nose is the most commonly infected part of the upper airways
For a complete picture of Rhinitis’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
